Axogen to Participate in the 76th Annual Meeting of the American Society for Surgery of the Hand
September 22 2021 - 7:00AM
Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and
marketing innovative surgical solutions for damage or discontinuity
to peripheral nerves, announced that it will participate in the
76th Annual Meeting of the American Society for Surgery of the Hand
(ASSH) being held in San Francisco from September 30-October 2,
2021. The meeting will offer both in-person and online attendance
options with live-streaming of select sessions and on-demand access
to pre-recorded scientific presentations.
As an Elite level partner of ASSH, Axogen will host an industry
forum breakfast symposium on Friday, October 1, 7:00-8:00 a.m. at
the Moscone Center. Innovations in nerve surgery that
transformed my practice will feature an expert panel who
will share pivotal moments and specific cases when Axogen
technologies impacted their approach to nerve repair and led them
to adopt a contemporary nerve repair algorithm.
Attending surgeons will have the opportunity to chat live with
Axogen scientists, clinicians, and other experts at Booth #950 in
the Solutions Center (exhibit hall). Staffed microscope stations
will be available at the booth, allowing surgeons to learn more
about microsurgical techniques, product handling, and other
innovative surgical solutions for peripheral nerve repair.
In addition to the breakfast symposium, Axogen will sponsor the
Women in Hand Surgery reception on Friday, October 1 at 6:30 p.m.,
provide in-kind lab materials for the Fellows pre-course, and
provide travel scholarships for two residents or Fellows to attend
the meeting in San Francisco.
“The annual ASSH meeting provides a unique and invaluable
opportunity for us to connect with surgeons and share our
innovative surgical solutions for nerve repair. We are confident we
will provide high value engagements and interactions for everyone
involved,” said Karen Zaderej, chairman, CEO, and president of
Axogen. “We look forward to engaging with surgeons, both in-person
and virtually, during our industry forum breakfast symposium, at
the Women in Hand Surgery reception, and throughout the meeting at
our exhibit booth.”
Axogen is proud to support various research, education, and
outreach programs of the ASSH throughout the year, including the
ASSH Touching Hands International Missions. These missions provide
life-changing hand surgeries, rehabilitation, and medical training
in the world’s most underserved communities.
About ASSHThe American Society for Surgery of
the Hand is the oldest medical society dedicated to the hand and
upper extremity. Its mission is to advance the science and practice
of hand and upper extremity surgery through education, research,
and advocacy on behalf of patients and practitioners. For more
information, please visit www.assh.org.
About AxogenAxogen (AXGN) is the
leading company focused specifically on the science, development,
and commercialization of technologies for peripheral nerve
regeneration and repair. Axogen employees are passionate about
helping to restore peripheral nerve function and quality of life to
patients with physical damage or transection to peripheral nerves
by providing innovative, clinically proven, and economically
effective repair solutions for surgeons and health care providers.
Peripheral nerves provide the pathways for both motor and sensory
signals throughout the body. Every day, people suffer traumatic
injuries or undergo surgical procedures that impact the function of
their peripheral nerves. Physical damage to a peripheral
nerve, or the inability to properly reconnect peripheral nerves,
can result in the loss of muscle or organ function, the loss of
sensory feeling, or the initiation of pain.
Axogen's platform for peripheral nerve repair features a
comprehensive portfolio of products, including Avance® Nerve Graft,
a biologically active off-the-shelf processed human nerve allograft
for bridging severed peripheral nerves without the comorbidities
associated with a second surgical site; Axoguard Nerve Connector®,
a porcine submucosa extracellular matrix (ECM) coaptation aid for
tensionless repair of severed peripheral nerves; Axoguard Nerve
Protector®, a porcine submucosa ECM product used to wrap and
protect damaged peripheral nerves and reinforce the nerve
reconstruction while preventing soft tissue attachments; and
Axoguard Nerve Cap®, a porcine submucosa ECM product used to
protect a peripheral nerve end and separate the nerve from the
surrounding environment to reduce the development of symptomatic or
painful neuroma. The Axogen portfolio of products is available in
the United States, Canada, the United Kingdom, South Korea, and
several other European and international countries.
Contact:Axogen, Inc.Peter Mariani, Executive Vice
President and Chief Financial
OfficerInvestorRelations@axogeninc.com
Axogen (NASDAQ:AXGN)
Historical Stock Chart
From Apr 2024 to May 2024
Axogen (NASDAQ:AXGN)
Historical Stock Chart
From May 2023 to May 2024